Compile Data Set for Download or QSAR
Report error Found 70 Enz. Inhib. hit(s) with all data for entry = 11902
TargetHomeodomain-interacting protein kinase 2(Human)
University of California

US Patent
LigandPNGBDBM658696(Sodium (R)-5-(sec- butylamino)benzo[h]isoquinoline...)
Affinity DataIC50: 300nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to HIPK2 inhibition was determined for the compounds of the invention by using Z′...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
Go to US Patent

TargetCasein kinase II subunit alpha(Human)
University of California

US Patent
LigandPNGBDBM658686(Sodium 5-(cyclohexylamino)benzo[h]isoquinoline- 8-...)
Affinity DataIC50: 300nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to CK2 alpha 1 inhibition was determined for the compounds of the invention by using Z&...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
Go to US Patent

TargetCasein kinase II subunit alpha(Human)
University of California

US Patent
LigandPNGBDBM658688((R)-5-(3-aminopiperidin-1-yl)benzo[h]isoquinoline-...)
Affinity DataIC50: 300nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to CK2 alpha 1 inhibition was determined for the compounds of the invention by using Z&...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
Go to US Patent

TargetCasein kinase II subunit alpha(Human)
University of California

US Patent
LigandPNGBDBM658689(Sodium 5-(cyclopentylamino)benzo[h]isoquinoline- 8...)
Affinity DataIC50: 300nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to CK2 alpha 1 inhibition was determined for the compounds of the invention by using Z&...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
Go to US Patent

TargetCasein kinase II subunit alpha(Human)
University of California

US Patent
LigandPNGBDBM658690(Sodium 5-(sec-butylamino)benzo[h]isoquinoline-8- c...)
Affinity DataIC50: 300nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to CK2 alpha 1 inhibition was determined for the compounds of the invention by using Z&...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
Go to US Patent

TargetHomeodomain-interacting protein kinase 2(Human)
University of California

US Patent
LigandPNGBDBM658691(Sodium 5-(cyclopropylamino)benzo[h]isoquinoline- 8...)
Affinity DataIC50: 300nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to HIPK2 inhibition was determined for the compounds of the invention by using Z′...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
Go to US Patent

TargetCasein kinase II subunit alpha(Human)
University of California

US Patent
LigandPNGBDBM658691(Sodium 5-(cyclopropylamino)benzo[h]isoquinoline- 8...)
Affinity DataIC50: 300nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to CK2 alpha 1 inhibition was determined for the compounds of the invention by using Z&...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
Go to US Patent

TargetCasein kinase II subunit alpha(Human)
University of California

US Patent
LigandPNGBDBM658692(Sodium 5-(cyclobutylamino)benzo[h]isoquinoline-8- ...)
Affinity DataIC50: 300nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to CK2 alpha 1 inhibition was determined for the compounds of the invention by using Z&...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
Go to US Patent

TargetCasein kinase II subunit alpha(Human)
University of California

US Patent
LigandPNGBDBM658693((S)-5-(sec-butylamino)benzo[h]isoquinoline-8- carb...)
Affinity DataIC50: 300nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to CK2 alpha 1 inhibition was determined for the compounds of the invention by using Z&...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
Go to US Patent

TargetCasein kinase II subunit alpha(Human)
University of California

US Patent
LigandPNGBDBM658694(Sodium 5-(piperidin-1-yl)benzo[h]isoquinoline-8- c...)
Affinity DataIC50: 300nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to CK2 alpha 1 inhibition was determined for the compounds of the invention by using Z&...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
Go to US Patent

TargetCasein kinase II subunit alpha(Human)
University of California

US Patent
LigandPNGBDBM658695(Sodium 5-(isopropylamino)benzo[h]isoquinoline-8- c...)
Affinity DataIC50: 300nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to CK2 alpha 1 inhibition was determined for the compounds of the invention by using Z&...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
Go to US Patent

TargetCasein kinase II subunit alpha(Human)
University of California

US Patent
LigandPNGBDBM658675(Sodium 5-bromobenzo[h]isoquinoline-8- carboxylate ...)
Affinity DataIC50: 300nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to CK2 alpha 1 inhibition was determined for the compounds of the invention by using Z&...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
Go to US Patent

TargetCasein kinase II subunit alpha(Human)
University of California

US Patent
LigandPNGBDBM658696(Sodium (R)-5-(sec- butylamino)benzo[h]isoquinoline...)
Affinity DataIC50: 300nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to CK2 alpha 1 inhibition was determined for the compounds of the invention by using Z&...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
Go to US Patent

TargetCasein kinase II subunit alpha(Human)
University of California

US Patent
LigandPNGBDBM658697(Sodium 5-bromo-1-chlorobenzo[h]isoquinoline-8- car...)
Affinity DataIC50: 300nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to CK2 alpha 1 inhibition was determined for the compounds of the invention by using Z&...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
Go to US Patent

TargetCasein kinase II subunit alpha(Human)
University of California

US Patent
LigandPNGBDBM658699(Sodium 1-chlorobenzo[h]isoquinoline-8-carboxylate ...)
Affinity DataIC50: 300nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to CK2 alpha 1 inhibition was determined for the compounds of the invention by using Z&...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
Go to US Patent

TargetCasein kinase II subunit alpha(Human)
University of California

US Patent
LigandPNGBDBM658700(Sodium 5-nitrobenzo[h]isoquinoline-8-carboxylate |...)
Affinity DataIC50: 300nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to CK2 alpha 1 inhibition was determined for the compounds of the invention by using Z&...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
Go to US Patent

TargetCasein kinase II subunit alpha(Human)
University of California

US Patent
LigandPNGBDBM658701(Sodium 5-cyanobenzo[h]isoquinoline-8-carboxylate |...)
Affinity DataIC50: 300nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to CK2 alpha 1 inhibition was determined for the compounds of the invention by using Z&...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
Go to US Patent

TargetCasein kinase II subunit alpha(Human)
University of California

US Patent
LigandPNGBDBM658702(Sodium 5-cyclopropylbenzo[h]isoquinoline-8- carbox...)
Affinity DataIC50: 300nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to CK2 alpha 1 inhibition was determined for the compounds of the invention by using Z&...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
Go to US Patent

TargetHomeodomain-interacting protein kinase 2(Human)
University of California

US Patent
LigandPNGBDBM658703(Sodium 1-amino-5-bromobenzo[h]isoquinoline-8- carb...)
Affinity DataIC50: 300nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to HIPK2 inhibition was determined for the compounds of the invention by using Z′...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
Go to US Patent

TargetCasein kinase II subunit alpha(Human)
University of California

US Patent
LigandPNGBDBM658703(Sodium 1-amino-5-bromobenzo[h]isoquinoline-8- carb...)
Affinity DataIC50: 300nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to CK2 alpha 1 inhibition was determined for the compounds of the invention by using Z&...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
Go to US Patent

TargetHomeodomain-interacting protein kinase 2(Human)
University of California

US Patent
LigandPNGBDBM658709(Sodium 1-amino-6-bromobenzo[h]isoquinoline-8- carb...)
Affinity DataIC50: 300nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to HIPK2 inhibition was determined for the compounds of the invention by using Z′...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
Go to US Patent

TargetCasein kinase II subunit alpha(Human)
University of California

US Patent
LigandPNGBDBM658683(Sodium 5-methylbenzo[h]isoquinoline-8- carboxylate...)
Affinity DataIC50: 300nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to CK2 alpha 1 inhibition was determined for the compounds of the invention by using Z&...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
Go to US Patent

TargetCasein kinase II subunit alpha(Human)
University of California

US Patent
LigandPNGBDBM658678(US11932606, Compound 4 | Sodium 5-((3- chloropheny...)
Affinity DataIC50: 300nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to CK2 alpha 1 inhibition was determined for the compounds of the invention by using Z&...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
Go to US Patent

TargetCasein kinase II subunit alpha(Human)
University of California

US Patent
LigandPNGBDBM658685(Sodium 5-(1H-pyrazol-3-yl)benzo[h]isoquinoline-8- ...)
Affinity DataIC50: 300nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to CK2 alpha 1 inhibition was determined for the compounds of the invention by using Z&...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
Go to US Patent

TargetCasein kinase II subunit alpha(Human)
University of California

US Patent
LigandPNGBDBM658678(US11932606, Compound 4 | Sodium 5-((3- chloropheny...)
Affinity DataIC50: 300nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to CK2 alpha 1 inhibition was determined for the compounds of the invention by using Z&...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
Go to US Patent

TargetCasein kinase II subunit alpha(Human)
University of California

US Patent
LigandPNGBDBM658681(Sodium 5-(pyridin-3-yl)benzo[h]isoquinoline-8- car...)
Affinity DataIC50: 300nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to CK2 alpha 1 inhibition was determined for the compounds of the invention by using Z&...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
Go to US Patent

TargetCasein kinase II subunit alpha(Human)
University of California

US Patent
LigandPNGBDBM658682(Sodium 5-(pyridin-4-yl)benzo[h]isoquinoline-8- car...)
Affinity DataIC50: 300nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to CK2 alpha 1 inhibition was determined for the compounds of the invention by using Z&...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
Go to US Patent

TargetCasein kinase II subunit alpha(Human)
University of California

US Patent
LigandPNGBDBM658677(Sodium 5-chlorobenzo[h]isoquinoline-8-carboxylate ...)
Affinity DataIC50: 300nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to CK2 alpha 1 inhibition was determined for the compounds of the invention by using Z&...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
Go to US Patent

TargetCasein kinase II subunit alpha(Human)
University of California

US Patent
LigandPNGBDBM658676(Sodium benzo[h]isoquinoline-8-carboxylate | US1193...)
Affinity DataIC50: 300nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to CK2 alpha 1 inhibition was determined for the compounds of the invention by using Z&...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
Go to US Patent

TargetCasein kinase II subunit alpha(Human)
University of California

US Patent
LigandPNGBDBM658684(Sodium 5-(6-aminopyridin-3- yl)benzo[h]isoquinolin...)
Affinity DataIC50: 300nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to CK2 alpha 1 inhibition was determined for the compounds of the invention by using Z&...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
Go to US Patent

TargetHomeodomain-interacting protein kinase 2(Human)
University of California

US Patent
LigandPNGBDBM658675(Sodium 5-bromobenzo[h]isoquinoline-8- carboxylate ...)
Affinity DataIC50: 300nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to HIPK2 inhibition was determined for the compounds of the invention by using Z′...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
Go to US Patent

TargetHomeodomain-interacting protein kinase 2(Human)
University of California

US Patent
LigandPNGBDBM658677(Sodium 5-chlorobenzo[h]isoquinoline-8-carboxylate ...)
Affinity DataIC50: 650nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to HIPK2 inhibition was determined for the compounds of the invention by using Z′...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
Go to US Patent

TargetHomeodomain-interacting protein kinase 2(Human)
University of California

US Patent
LigandPNGBDBM658702(Sodium 5-cyclopropylbenzo[h]isoquinoline-8- carbox...)
Affinity DataIC50: 650nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to HIPK2 inhibition was determined for the compounds of the invention by using Z′...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
Go to US Patent

TargetHomeodomain-interacting protein kinase 2(Human)
University of California

US Patent
LigandPNGBDBM658678(US11932606, Compound 4 | Sodium 5-((3- chloropheny...)
Affinity DataIC50: 650nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to HIPK2 inhibition was determined for the compounds of the invention by using Z′...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
Go to US Patent

TargetCasein kinase II subunit alpha(Human)
University of California

US Patent
LigandPNGBDBM658706(Sodium 5-bromo-1- (methylamino)benzo[h]isoquinolin...)
Affinity DataIC50: 650nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to CK2 alpha 1 inhibition was determined for the compounds of the invention by using Z&...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
Go to US Patent

TargetHomeodomain-interacting protein kinase 2(Human)
University of California

US Patent
LigandPNGBDBM658701(Sodium 5-cyanobenzo[h]isoquinoline-8-carboxylate |...)
Affinity DataIC50: 650nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to HIPK2 inhibition was determined for the compounds of the invention by using Z′...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
Go to US Patent

TargetHomeodomain-interacting protein kinase 2(Human)
University of California

US Patent
LigandPNGBDBM658678(US11932606, Compound 4 | Sodium 5-((3- chloropheny...)
Affinity DataIC50: 650nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to HIPK2 inhibition was determined for the compounds of the invention by using Z′...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
Go to US Patent

TargetHomeodomain-interacting protein kinase 2(Human)
University of California

US Patent
LigandPNGBDBM658700(Sodium 5-nitrobenzo[h]isoquinoline-8-carboxylate |...)
Affinity DataIC50: 650nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to HIPK2 inhibition was determined for the compounds of the invention by using Z′...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
Go to US Patent

TargetHomeodomain-interacting protein kinase 2(Human)
University of California

US Patent
LigandPNGBDBM658707(1-Amino-5-bromobenzo[h]isoquinoline-8- carboxamide...)
Affinity DataIC50: 650nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to HIPK2 inhibition was determined for the compounds of the invention by using Z′...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
Go to US Patent

TargetCasein kinase II subunit alpha(Human)
University of California

US Patent
LigandPNGBDBM658708(Sodium 5-bromo-1-methoxybenzo[h]isoquinoline-8- ca...)
Affinity DataIC50: 650nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to CK2 alpha 1 inhibition was determined for the compounds of the invention by using Z&...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
Go to US Patent

TargetHomeodomain-interacting protein kinase 2(Human)
University of California

US Patent
LigandPNGBDBM658697(Sodium 5-bromo-1-chlorobenzo[h]isoquinoline-8- car...)
Affinity DataIC50: 650nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to HIPK2 inhibition was determined for the compounds of the invention by using Z′...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
Go to US Patent

TargetCasein kinase II subunit alpha(Human)
University of California

US Patent
LigandPNGBDBM658709(Sodium 1-amino-6-bromobenzo[h]isoquinoline-8- carb...)
Affinity DataIC50: 650nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to CK2 alpha 1 inhibition was determined for the compounds of the invention by using Z&...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
Go to US Patent

TargetHomeodomain-interacting protein kinase 2(Human)
University of California

US Patent
LigandPNGBDBM658689(Sodium 5-(cyclopentylamino)benzo[h]isoquinoline- 8...)
Affinity DataIC50: 650nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to HIPK2 inhibition was determined for the compounds of the invention by using Z′...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
Go to US Patent

TargetHomeodomain-interacting protein kinase 2(Human)
University of California

US Patent
LigandPNGBDBM658686(Sodium 5-(cyclohexylamino)benzo[h]isoquinoline- 8-...)
Affinity DataIC50: 650nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to HIPK2 inhibition was determined for the compounds of the invention by using Z′...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
Go to US Patent

TargetHomeodomain-interacting protein kinase 2(Human)
University of California

US Patent
LigandPNGBDBM658684(Sodium 5-(6-aminopyridin-3- yl)benzo[h]isoquinolin...)
Affinity DataIC50: 650nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to HIPK2 inhibition was determined for the compounds of the invention by using Z′...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
Go to US Patent

TargetHomeodomain-interacting protein kinase 2(Human)
University of California

US Patent
LigandPNGBDBM658690(Sodium 5-(sec-butylamino)benzo[h]isoquinoline-8- c...)
Affinity DataIC50: 650nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to HIPK2 inhibition was determined for the compounds of the invention by using Z′...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
Go to US Patent

TargetHomeodomain-interacting protein kinase 2(Human)
University of California

US Patent
LigandPNGBDBM658683(Sodium 5-methylbenzo[h]isoquinoline-8- carboxylate...)
Affinity DataIC50: 650nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to HIPK2 inhibition was determined for the compounds of the invention by using Z′...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
Go to US Patent

TargetHomeodomain-interacting protein kinase 2(Human)
University of California

US Patent
LigandPNGBDBM658692(Sodium 5-(cyclobutylamino)benzo[h]isoquinoline-8- ...)
Affinity DataIC50: 650nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to HIPK2 inhibition was determined for the compounds of the invention by using Z′...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
Go to US Patent

TargetHomeodomain-interacting protein kinase 2(Human)
University of California

US Patent
LigandPNGBDBM658694(Sodium 5-(piperidin-1-yl)benzo[h]isoquinoline-8- c...)
Affinity DataIC50: 650nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to HIPK2 inhibition was determined for the compounds of the invention by using Z′...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
Go to US Patent

TargetCasein kinase II subunit alpha(Human)
University of California

US Patent
LigandPNGBDBM658680(Sodium 5-(4-chlorophenyl)benzo[h]isoquinoline-8- c...)
Affinity DataIC50: 650nMAssay Description:The half maximal inhibitory concentration (IC50) with respect to CK2 alpha 1 inhibition was determined for the compounds of the invention by using Z&...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2024
Entry Details
Go to US Patent

Displayed 1 to 50 (of 70 total ) | Next | Last >>
Jump to: